Cruz I, Snijders P J F, Van Houten V, Vosjan M, Van der Waal I, Meijer C J L M
Department of Oral and Maxillofacial Surgery/Oral Pathology/ACTA, Vrije Universiteit Medical Centre, Amsterdam, The Netherlands.
J Clin Pathol. 2002 Nov;55(11):834-40. doi: 10.1136/jcp.55.11.834.
To identify immunostaining patterns that are predictive for p53 mutations and to investigate whether p53 mutations are associated with established risk factors for oral squamous cell carcinoma (OSCC).
Fifty five OSCCs were investigated for p53 protein expression by immunohistochemistry (IHC). Ten of these cases, including five p53 immunopositive and five p53 immunonegative cases, were subjected to microdissection of representative tumour areas followed by sequence analysis for the detection of TP53 mutations.
Paired IHC and sequence analysis revealed that p53 immunoexpression in more than 25% of tumour cells was indicative of TP53 mutations, whereas p53 immunonegativity was not informative. Therefore, for p53 immunohistochemical interpretation, p53 immunonegative cases were excluded from the analysis and the cut off value for p53 immunoexpression was set at 25%. Of the OSCCs showing any p53 immunoexpression, 64% revealed staining in more than 25% of the tumour cells. p53 immunoexpression in more than 25% of the neoplastic cells was significantly associated with smoking but not with alcohol consumption. No significant association with smoking habits was found when OSCCs were dichotomised into p53 immunonegative and p53 immunopositive.
In OSCCs the following conclusions can be made: (1) p53 immunonegativity is not informative for TP53 mutations; (2) 25% p53 immunopositive cells appears to be a good cut off value to predict TP53 mutations; (3) p53 immunostaining patterns that appeared to be predictive for TP53 mutations were associated with the smoking habits of the patients.
确定可预测p53突变的免疫染色模式,并研究p53突变是否与口腔鳞状细胞癌(OSCC)既定的风险因素相关。
通过免疫组织化学(IHC)对55例OSCC进行p53蛋白表达研究。其中10例病例,包括5例p53免疫阳性和5例p53免疫阴性病例,对代表性肿瘤区域进行显微切割,随后进行序列分析以检测TP53突变。
配对的IHC和序列分析显示,超过25%的肿瘤细胞中p53免疫表达提示TP53突变,而p53免疫阴性则无诊断意义。因此,对于p53免疫组化解读,p53免疫阴性病例被排除在分析之外,p53免疫表达的临界值设定为25%。在显示任何p53免疫表达的OSCC中,64%在超过25%的肿瘤细胞中呈染色阳性。超过25%的肿瘤细胞中p53免疫表达与吸烟显著相关,但与饮酒无关。当将OSCC分为p53免疫阴性和p53免疫阳性时,未发现与吸烟习惯有显著关联。
对于OSCC可得出以下结论:(1)p53免疫阴性对TP53突变无诊断意义;(2)25%的p53免疫阳性细胞似乎是预测TP53突变的良好临界值;(3)似乎可预测TP53突变的p53免疫染色模式与患者的吸烟习惯相关。